Home › Research › Topics › italian
italian
3 studies tagged italian, dated 2017-01-01 to 2026-10-15. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Updated Italian intersocietal recommendations for the appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease 2026-10-15
- Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus 2026-10-09
- The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 2017-01-01
Studies
3 studies carry this tag.
Date range
2017 to 2026
Top journals
- Journal of Alzheimer's disease : JAD 1
- Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 1
- The journal of prevention of Alzheimer's disease 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
With the European authorisation of lecanemab and donanemab, Italy is entering the era of disease-modifying therapy for early symptomatic Alzheimer's disease.
-
This consensus provides a pragmatic framework to support the reorganisation of AD care in Italy, ensuring that every patient is directed to the most appropriate level of care across a flexible regional network.
-
Although the use of cerebrospinal fluid (CSF) amyloid β1-42 (Aβ42), tau (T-tau), and phosphorylated tau (p-tau181) gives added diagnostic and prognostic values, the diffusion is still limited in clinical practice and only a restricted number of patients receive an integrated clinico-biological diagnosis.